+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Boronic Acids 1391926-50-3
1391926-50-3,MFCD17214384
Catalog No.:AA001AEA

1391926-50-3 | tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98+%
in stock  
$29.00   $21.00
- +
250mg
98+%
in stock  
$52.00   $36.00
- +
1g
97%
in stock  
$123.00   $87.00
- +
5g
97%
in stock  
$421.00   $295.00
- +
25g
97%
in stock  
$1,974.00   $1,382.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001AEA
Chemical Name:
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate
CAS Number:
1391926-50-3
Molecular Formula:
C18H25BN2O4
Molecular Weight:
344.2131
MDL Number:
MFCD17214384
SMILES:
O=C(n1ccc2c1nccc2B1OC(C(O1)(C)C)(C)C)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
516  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SPHAERAPHARMA-WO2012/101654,2012,A2

[2]CurrentPatentAssignee:SPHAERAPHARMA-WO2014/16849,2014,A2

[1]Patent:WO2017/24021,2017,A1.Locationinpatent:Paragraph0703;0704

[2]Patent:WO2017/24004,2017,A1.Locationinpatent:Paragraph0685

[3]Patent:WO2017/23980,2017,A1.Locationinpatent:Paragraph0685

[4]Patent:WO2017/23996,2017,A1.Locationinpatent:Paragraph0685

[5]Patent:WO2012/101654,2012,A2.Locationinpatent:Page/Pagecolumn59-60

[6]Patent:WO2014/16849,2014,A2.Locationinpatent:Page/Pagecolumn115;116

[1]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24004,2017,A1

[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23980,2017,A1

[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23996,2017,A1

1391926-50-3   
(1-(tert-butoxycarbonyl)-4-(pyridin-2-yl)-1H-pyrrolo2,3-bpyridin-2-yl)boronicacid 

[1]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24004,2017,A1

[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23980,2017,A1

[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23996,2017,A1

109-04-6    1391926-50-3   
tert-butyl4-(pyridin-2-yl)-1H-pyrrolo2,3-bpyridine-1-carboxylate 

[1]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1Locationinpatent:Paragraph0703;0705

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24004,2017,A1Locationinpatent:Paragraph0686

[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23980,2017,A1Locationinpatent:Paragraph0686

[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23996,2017,A1Locationinpatent:Paragraph0686

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1391926-50-3
1021918-86-4

1021918-86-4

 942070-47-5

942070-47-5

 942070-54-4

942070-54-4

 1370616-23-1

1370616-23-1

 2159138-80-2

2159138-80-2

 2159138-80-2

2159138-80-2
Building Blocks
More >
Tags:1391926-50-3 Molecular Formula|1391926-50-3 MDL|1391926-50-3 SMILES|1391926-50-3 tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate